The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5
Open accessAbstract
Introduction Hypertension remains a major public health concern, with significant morbidity and mortality worldwide. Despite the availability of various antihypertensive medications, blood pressure control remains suboptimal in many individuals. During the last decades, KV7.4 and KV7.5, which were already known from the view of neuronal regulation, emerged as possible important players in the regulation of vascular tone and blood pressure.Areas covered This review covers physiological functions and current advancements in the development of KV7.4 and KV7.5 channel modulators. The authors highlight the structural elements likely to be important for the future design of KV7subtype-selective modulators, underscoring their potential as an innovative hypertension treatment.Expert opinion Extensive research has been focused on targeting neuronal KV7.2 and KV7.3 channels, while KV7.4 and KV7.5 attracted less attention. Many of the developed compounds represent derivatives of flupirtine or retigabine, whereby subtype channel selectivity has only been demonstrated for a handful of individual compounds. Novel substances address additional sites within the binding pocket by incorporating new functional groups. A comprehensive and systematic evaluation of a compound set with significant subtype selectivity should be performed. The discovery of new highly active, less toxic, and selective compounds, therefore, remains the goal of further research in the coming years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Natural-product leads like echinocystic acid and endogenous modulators such as dehydroepiandrosterone sulfate (DHEAS) expand chemotype space and suggest allosteric stabilization strategies that preserve physiological gating [267,269].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [269]
Citations
Cites
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
Physiological roles and properties of potassium channels in arterial smooth muscle
Nelson, M. T., & Quayle, J. M. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.4.c799 · Cited by 2,153 · cited 1×
“Consequently, membrane hyperpolarization will inhibit smooth muscle cell contraction or excitability [8].”
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031 · cited 1×
“All structures were prepared with the Protein Preparation Wizard [76], and docking calculations were performed using Glide [77] (Schrödinger release 2024.2). channels, thus it appears to be highly selective [89,90].”
InfluentialPositional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,759 · cited 1×
“In humans, mutations in all five Kcnq genes were described to cause disease phenotypes including long QT syndrome (K V 7.1) [17], epileptic encephalopathy (K V 7.2/3) [18,19], deafness (K V 7.4) [20] and complex central nervous system symptoms like intellectual disability and epileptic…”
InfluentialA Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“…in all five Kcnq genes were described to cause disease phenotypes including long QT syndrome (K V 7.1) [17], epileptic encephalopathy (K V 7.2/3) [18,19], deafness (K V 7.4) [20] and complex central nervous system symptoms like intellectual disability and epileptic encephalopathy (K V 7.5)…”
InfluentialA pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
Charlier, C., Singh, N. A., Ryan, S. G., Lewis, T. B., Reus, B. E., Leach, R. J., & Leppert, M. (1998) · Nature Genetics · doi:10.1038/ng0198-53 · Cited by 937 · cited 1×
“…in all five Kcnq genes were described to cause disease phenotypes including long QT syndrome (K V 7.1) [17], epileptic encephalopathy (K V 7.2/3) [18,19], deafness (K V 7.4) [20] and complex central nervous system symptoms like intellectual disability and epileptic encephalopathy (K V 7.5) [21–23].”
InfluentialKubisch, C., Schroeder, B. C., Friedrich, T., Lütjohann, B., El-Amraoui, A., Marlin, S., Petit, C., & Jentsch, T. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80556-5 · Cited by 867 · cited 1×
“…in all five Kcnq genes were described to cause disease phenotypes including long QT syndrome (K V 7.1) [17], epileptic encephalopathy (K V 7.2/3) [18,19], deafness (K V 7.4) [20] and complex central nervous system symptoms like intellectual disability and epileptic encephalopathy (K V 7.5) [21–23].”
InfluentialNeuronal KCNQ potassium channels:physislogy and role in disease
Jentsch, T. J. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036198 · Cited by 849
Brown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676
KCNQ5, a Novel Potassium Channel Broadly Expressed in Brain, Mediates M-type Currents
Schroeder, B. C., Hechenberger, M., Weinreich, F., Kubisch, C., & Jentsch, T. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003245200 · Cited by 387
Research works printed but not linked: 3
- 10.1111/micc.12434 · DOI
- 10.1124/mol.58.2.253 · doi:10.1124/mol.58.2.253 · Paper page
- Yu H, Wu M, Hopkins C, et al. A small molecule activator of KCNQ2 and KCNQ4 channels. In: Probe reports from the NIH molecular libraries program. Bethesda (MD): National Center for Biotechnology Information (US); 2010.
Cited by
Lemke, J., Mengers, N., Schmidt, L., Schulig, L., König, S., Rosendahl, P., Bartz, F., Garscha, U., Bednarski, P. J., & Link, A. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03112 · Cited by 6
Self-citationGomes, K. N., Mawandji, N. B. D. S., Schereider, I. R. G., Oliveira, E. P. G., Vieira, J. M., Lopes, A. B., Graceli, J. B., Dantas, J. A., Cardoso, L. S., Vassallo, D. V., et al. (2025) · Nutrients · doi:10.3390/nu17152395 · Cited by 6
“Potassium channels in arterial smooth muscle cells are important modulators of vascular tone, and their dysfunction may contribute to the development of vascular diseases such as atherosclerosis [40,41].”
Metabolic Regulation of Vascular Smooth Muscle Potassium Channels by Perivascular Adipose Tissue
Gollasch, M., Kaßmann, M., Alves, D. T., Garscha, U., & Tsvetkov, D. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.321693 · Cited by 3
Self-citationLu, T., Liutkevičienė, R., Rovīte, V., Gao, Z.-H., & Wu, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041504 · Cited by 2
“However, in specific locations, other subunits may also contribute to M-like currents [6,16].”
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L.
- Affiliations
- Universität Greifswald (DE)
- Universitätsmedizin Greifswald (DE)
- Corresponding author
- Schulig, Lukas
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2024-12-09
- Volume
- 20
- Issue
- 1
- Pages
- 47-62
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W4405020509
- Cited by
- 6
- References
- 135
- Citations by year
- 2026: 2 · 2025: 4
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Expert Opinion on Drug Discovery (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (GO766/12–3, GO766/15–2, GO766/22–3, SFB 1365)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Kv7.4, Kv7.5, voltage-gated potassium channels, channel modulators, hypertension, blood pressure regulation, vascular tone, drug design, potassium channel structure
- MeSH terms
- Animals, Antihypertensive Agents, Blood Pressure, Carbamates, Humans, Hypertension, Phenylenediamines, Drug Design, KCNQ Potassium Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5. https://app.cochat.ai/papers/10.1080/17460441.2024.2438226
- The paper
- Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L. (2025). Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2024.2438226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.